日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

European Code Against Cancer 5th edition: 14 ways you can help prevent cancer

欧洲抗癌守则第五版:14种预防癌症的方法

Espina, Carolina; Ritchie, David; Riboli, Elio; Kromhout, Hans; Franceschi, Silvia; Lansdorp-Vogelaar, Iris; Marteau, Theresa M; Bakogianni, Ioanna; Vilahur, Nadia; Alberts, Catherina J; Ivanus, Urska; Feliu, Ariadna; D'Souza, Erica; Zeeb, Hajo; Mitrou, Giota; Albreht, Tit; Dillner, Joakim; Foucaud, Jérôme; Manczuk, Marta; Martin-Moreno, Jose María; Medema, Rene H; Murray, Deirdre; Nagy, Peter; Nicula, Florian; Nyangasi, Mary; Steindorf, Karen; Tjønneland, Anne; Cecchini, Michele; Corbex, Marilys; Stepien, Magdalena; Yared, Wendy; Carvalho, André L; Schüz, Joachim

Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System Organ Class-Level Post-Marketing Reporting Patterns in EudraVigilance

替泽帕肽与司美格鲁肽和利拉鲁肽的比例失衡分析:EudraVigilance 中按系统器官类别划分的上市后报告模式

Marin, Ruxandra Cristina; Vesa, Cosmin Mihai; Tit, Delia Mirela; Radu, Andrei-Flavius; Bungau, Gabriela S

Divergent System Organ Class Safety Profiles of Isotretinoin Versus Topical Retinoids: An EudraVigilance Disproportionality Analysis

异维A酸与外用维甲酸类药物在不同系统器官类别中的安全性特征:一项EudraVigilance不均衡性分析

Szilagyi, Denisa Viola; Tit, Delia Mirela; Marin, Ruxandra Cristina; Bungau, Gabriela S; Toma, Mirela Marioara; Pasca, Manuela Bianca; Gitea, Daniela; Endres, Laura Maria

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

开发以证据为基础、经济有效的P4癌症药物,以推动预防、治疗、患者护理方面的创新,并减少医疗保健不平等现象。

Ringborg, Ulrik; von Braun, Joachim; Celis, Julio; Berns, Anton; Baumann, Michael; Albreht, Tit; Abou-Zeid, Nancy; Bagnato, Vanderlei; Brandts, Christian; Chen, Chien-Jen; di Pietro, Massimiliano; Dosanjh, Manjit; Dubois, Thomas; Eggermont, Alexander; Eggert, Angelika; Ernberg, Ingemar; Faithfull, Sara; Förner, Johannes; Fröhling, Stefan; Heitor, Manuel; Hood, Leroy; Jiang, Wei; Jönsson, Bengt; Kannan, Ravi; Leptin, Maria; Li, Su; Lindgren, Peter; Lowy, Douglas; Ma, Jun; Markham, Alex; Nagy, Péter; Oberst, Simon; Parker, M Iqbal; Rodin, Danielle; Ryan, Kevin; Schüz, Joachim; Sullivan, Richard; Tabernero, Josep; Turkson, Peter; Várhelyi, Oliver; Varmus, Harold; Wang, Chijie; Weiderpass, Elisabete; Wilking, Nils

Invisible frontlines: the overlooked health consequences of the war in Iran

隐形战线:伊朗战争被忽视的健康后果

Correia, Tiago; Albreht, Tit; Squires, Neil; Marchandise, Charlotte; McKee, Martin

Polypharmacy and Drug-Drug Interaction Architecture in Hospitalized Cardiovascular Patients: Insights from Real-World Analysis

住院心血管疾病患者的多重用药及药物相互作用架构:来自真实世界分析的启示

Radu, Andrei-Flavius; Radu, Ada; Bungau, Gabriela S; Tit, Delia Mirela; Vesa, Cosmin Mihai; Jurca, Tunde; Uivarosan, Diana; Gitea, Daniela; Brata, Roxana; Bustea, Cristiana

Youth participation in public health: from presence to power

青年参与公共卫生:从存在到权力

Albreht, Tit; Marchandise, Charlotte; Kluge, Hans Henri P; Izhyk, Olha; Salvi, Cristiana; Habersaat, Katrine Bach; Franco, Manuel; Elzinga, Jennie

Civil society is essential public health infrastructure that Europe cannot afford to lose

公民社会是欧洲不能失去的重要公共卫生基础设施。

Sokolović, Milka; Lauriola, Paolo; Albreht, Tit; Marchandise, Charlotte

Investing for sustainable health and well-being: bringing the Helsinki commitment to life

投资于可持续的健康与福祉:将赫尔辛基承诺付诸实践

Albreht, Tit; Marchandise, Charlotte

From Policy to Practice: Community Pharmacists' Self-Reported Counseling Role in Pharmaceutical Waste Management

从政策到实践:社区药剂师在药物废物管理中自我报告的咨询作用

Cirstea, Ilie; Nemeth, Tiberiu Sebastian; Tit, Delia Mirela; Ghitea, Timea Claudia; Marin, Ruxandra Cristina; Uivaraseanu, Bogdan; Radu, Andrei-Flavius; Bungau, Gabriela S